BAX Baxter International Inc

Price (delayed)

$79.53

Market cap

$40.63B

P/E Ratio

44.43

Dividend/share

$0.96

EPS

$1.79

Enterprise value

$43.24B

Sector: Healthcare
Industry: Medical Instruments & Supplies

Highlights

The company's equity rose by 13% YoY and by 5% QoQ
The revenue is up by 3.4% year-on-year
BAX's P/E is 43% above its 5-year quarterly average of 31.1
BAX's net income is down by 31% year-on-year

Key stats

What are the main financial stats of BAX
Market
Shares outstanding
510.82M
Market cap
$40.63B
Enterprise value
$43.24B
Valuations
Price to earnings (P/E)
44.43
Price to book (P/B)
4.7
Price to sales (P/S)
3.52
EV/EBIT
44.77
EV/EBITDA
24.23
EV/Sales
3.75
Earnings
Revenue
$11.53B
EBIT
$966M
EBITDA
$1.79B
Free cash flow
$1.32B
Per share
EPS
$1.79
Free cash flow per share
$2.59
Book value per share
$16.92
Revenue per share
$22.57
TBVPS
$29.99
Balance sheet
Total assets
$20.1B
Total liabilities
$11.5B
Debt
$6.98B
Equity
$8.57B
Working capital
$5.61B
Liquidity
Debt to equity
0.81
Current ratio
2.64
Quick ratio
1.86
Net debt/EBITDA
1.47
Margins
EBITDA margin
15.5%
Gross margin
40.7%
Net margin
7.9%
Operating margin
15.1%
Efficiency
Return on assets
4.7%
Return on equity
11.3%
Return on invested capital
6.9%
Return on capital employed
5.8%
Return on sales
8.4%
Dividend
Dividend yield
1.2%
DPS
$0.96
Payout ratio
53.4%

BAX stock price

How has the Baxter International stock price performed over time
Intraday
0.01%
1 week
-0.65%
1 month
0.61%
1 year
-12.67%
YTD
-0.88%
QTD
-0.88%

Financial performance

How have Baxter International's revenue and profit performed over time
Revenue
$11.53B
Gross profit
$4.69B
Operating income
$1.75B
Net income
$911M
Gross margin
40.7%
Net margin
7.9%
Baxter International's net margin has decreased by 34% YoY and by 2.5% from the previous quarter
BAX's net income is down by 31% year-on-year
Baxter International's operating income has increased by 7% YoY
The operating margin has increased by 3.4% YoY but it has decreased by 3.2% from the previous quarter

Growth

What is Baxter International's growth rate over time

Valuation

What is Baxter International stock price valuation
P/E
44.43
P/B
4.7
P/S
3.52
EV/EBIT
44.77
EV/EBITDA
24.23
EV/Sales
3.75
BAX's P/E is 43% above its 5-year quarterly average of 31.1
The EPS has contracted by 31% YoY
The company's equity rose by 13% YoY and by 5% QoQ
BAX's P/B is 12% above its 5-year quarterly average of 4.2 but 10% below its last 4 quarters average of 5.2
BAX's P/S is 7% above its 5-year quarterly average of 3.3 but 4.9% below its last 4 quarters average of 3.7
The revenue is up by 3.4% year-on-year

Efficiency

How efficient is Baxter International business performance
The ROIC has plunged by 50% YoY and by 5% from the previous quarter
The ROS has contracted by 43% YoY and by 4.5% from the previous quarter
The ROA has contracted by 41% YoY and by 6% from the previous quarter
The company's return on equity fell by 34% YoY and by 4.2% QoQ

Dividends

What is BAX's dividend history
DPS
$0.96
Dividend yield
1.2%
Payout ratio
53.4%
Recent dividends

Financial health

How did Baxter International financials performed over time
The total assets is 75% more than the total liabilities
The total assets has grown by 16% YoY and by 3.3% from the previous quarter
The current ratio fell by 11% QoQ and by 4.3% YoY
Baxter International's debt is 19% less than its equity
The company's equity rose by 13% YoY and by 5% QoQ
The debt to equity has increased by 11% year-on-year but it has declined by 3.6% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.